Kenneth Frazier is to be the next chief executive of Merck & Co from 1 January 2011 following his election …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

